Pregnancies in women with systemic sclerosis have high live birth rates but higher rates of preeclampsia, postpartum ...

NEW YORK--(BUSINESS WIRE)--Gameto, a biotechnology company dedicated to advancing treatment option in women's health, announced today the world’s first live human birth using Fertilo, an ovarian ...

- Breakthrough ovarian support cell technology eliminates approximately 80% of hormone injections required with conventional in-vitro fertilization (IVF) NEW YORK--(BUSINESS WIRE)--Gameto, a ...